9-fluoro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-1,5,6,7-tetrahydropyrido[3,2,1-ij]quinoline-2-carboxylic acid-d9;9-Fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-1H,5H-benzo[ij]quinolizine-2-carboxylic Acid-d9; Jinofloxacin-d9; OPC-7251-d9; Acuatim-d9;Nadifloxacin-d9
Nadifloxacin-d9 is a fully characterized chemical compound used as a reference standard of API Difloxacin. The standard offered is compliant with regulatory guidelines. Nadifloxacin-d9 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 124858-35-1 (non-labelled)
